Clovis Oncology to Present at the 2014 Morgan Stanley Global Healthcare Conference

Morgan Stanley Global Healthcare Conference 2014

BOULDER, Colo.--()--Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, the Company’s president and CEO, will present at the 2014 Morgan Stanley Global Healthcare Conference on Tuesday, September 9, at 4:05pm EST. The conference is being held at the Grand Hyatt in New York City.

A live webcast of the corporate presentation at the conference will be accessible through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.

Contacts

Clovis Oncology
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com

Release Summary

Clovis Oncology to Present at the 2014 Morgan Stanley Global Healthcare Conference

Contacts

Clovis Oncology
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com